Although there are some reports indicating the beneficial effects of HDAC inhibitors in human subjects suffering from LIDs and some HDAC inhibitors have recently entered clinical trials for PD, still there are much awaited results. This evidence concerns the gene HDAC9 and Parkinson disease.